Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Novartis Forms Regional Collab in Nagasaki for CV, Respiratory Diseases
April 19, 2022
- Shionogi, NEC Pair Up for Novel Hepatitis B Therapeutic Vaccine Research
April 19, 2022
- Nippon Boehringer Ingelheim Logs 6.7% Sales Rise in 2021
April 19, 2022
- JCR, Teijin Ditch Regenerative Medicine Deal after Japan PI/II Flop
April 19, 2022
- Otsuka Grabs Rights to Osaka University’s New Antitumor Antibody
April 18, 2022
- Mediceo Gets 6-Month Suspension from National Hospital Organization Bids
April 18, 2022
- Female Manager Ratio at Japan Drug Makers Finally Hits 10%, Foreign Peers Near 25%: Jiho Poll
April 15, 2022
- Astellas’ Padcev Receives Bladder Cancer Nod in Europe
April 15, 2022
- Bayer Yakuhin Sees 2021 Sales Skid 0.6% but Still Reach Target, Retains Spot in Top 10
April 15, 2022
- Shionogi Unit, LPIXEL to Study AI-Based Drug Discovery Tech for Infectious Diseases
April 15, 2022
- Takeda’s HAE Med Takhzyro Hits Targets in Global PIII for Pediatric Patients
April 14, 2022
- Teratogenicity Data for COVID Pill Already Submitted to Japan Regulators: Shionogi
April 14, 2022
- Lumakras Nears Japan Market, Amgen Eyes Simultaneous Launch with US for Next 5 Oncology Drugs: EVP
April 14, 2022
- Innovative Brands to Drive Return to Growth at Lilly Japan after 2 Years of Decline: President
April 13, 2022
- Myovant’s Myfembree Label Expansion Plan Stumbles in FDA Review
April 13, 2022
- Opdivo Gets Adjuvant Nod for Urothelial Cancer in Taiwan
April 13, 2022
- Daiichi Sankyo Espha Launches Follow-On AG for Diart
April 13, 2022
- Jury Finds Enhertu Infringes Seagen Patent, Awards US$41.8 Million in Damages
April 12, 2022
- CEPI to Fund NEC’s AI-Based Coronavirus Vaccine Development
April 12, 2022
- Pertussis, Diphtheria, Tetanus, Polio, Hib Vaccine Filed in Japan: BIKEN/Mitsubishi
April 12, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…